胃癌患者血清miR-518a-3p、miR-376c-3p、sPD-L1、sCTLA-4表达水平与临床病理特征及预后的关系研究OA
Serum Levels of miR-518a-3p,miR-376c-3p,sPD-L1,and sCTLA-4 in Gastric Cancer Patients and Their Association with Clinicopathological Characteristics and Prognosis
目的 探讨血清miR-518a-3p、miR-376c-3p、可溶性细胞毒性T淋巴细胞相关抗原4(sCTLA-4)和可溶性程序性死亡-配体1(sPD-L1)在胃癌患者中的表达水平,并分析其与临床病理特征及预后的关系.方法 回顾性纳入2019年9月~2022年6月于滁州市第一人民医院就诊的179例胃癌患者为病例组,并同期158例健康体检者为对照组.比较两组血清中miR-518a-3p、miR-376c-3p及sPD-L1及sCTLA-4的表达水平,分析其与胃癌患者临床病理特征之间的关联;采用受试者操作特征(ROC)曲线下面积(AUC)评估各指标对胃癌发生及预后的预测价值;通过Kaplan-Meier生存曲线比较不同表达水平组胃癌患者的3年总生存率(OS).结果 病例组血清miR-518a-3p(1.98±0.45)、miR-376c-3p(0.99±0.34)水平明显低于对照组(4.12±1.23、3.67±1.23),血清sPD-L1(4.67±1.77)、sCTLA-4(10.21±2.34)水平明显高于对照组(1.51±0.45、4.79±1.55)(t=21.694~27.971,均P<0.05).死亡组患者血清sPD-L1(6.02±1.47)、sCTLA-4(11.67±2.89)水平明显高于生存组(3.78±1.64、6.56±1.59),miR-518a-3p(1.89±0.56)、miR-376c-3p(1.07±0.31)水平明显低于生存组(3.68±1.29、3.45±1.23)(t=9.571~17.251,均P<0.05).ROC曲线表明,上述四项指标联合诊断胃癌发生的AUC为0.992,也明显高于四者单独预测(Z=3.759~6.103,均P<0.001);联合预测胃癌患者预后的AUC为0.997,明显高于四项单独预测时的AUC(Z=2.176~5.534,均P<0.05).其表达均与TNM分期、肿瘤直径、淋巴结转移、肿瘤分化程度以及远处转移有关(miR-514b-3p:t=10.490~14.274、miR-376c-3p:t=13.021~16.528、sPD-L1:t=6.143~8.204、sCTLA-4:t=8.626~13.183,均P<0.05).Ka-plan-Meier生存曲线结果显示,miR-518a-3p及miR-376c-3p低表达组患者的OS明显低于其高表达组(Log-rank χ2=82.138、158.448,均P<0.05),sPD-L1及sCTLA-4高表达组患者的OS明显低于其低表达组(Log-rank χ2=42.328、139.243,均P<0.05).结论 血清miR-518a-3p和miR-376c-3p低表达以及sPD-L1、sCTLA-4高表达与胃癌患者临床病理特征及预后不良显著相关,联合检测对胃癌预后评估具有重要临床价值.
Objective To investigate the serum expression levels of microRNA(miR)-518a-3p,miR-376c-3p,soluble cytotoxic T lymphocyte-associated protein 4(sCTLA-4),and soluble programmed death-ligand 1(sPD-L1)in gastric cancer patients,and to analyze their associations with clinical pathological characteristics and prognosis.Methods This retrospective study included 179 gastric cancer patients treated at the First People's Hospital of Chuzhou from September 2019 to June 2022 as the gastric cancer group,and 158 healthy individuals undergoing routine physical examinations during the same period as the control group.Serum levels of miR-518a-3p,miR-376c-3p,sPD-L1,and sCTLA-4 were measured and compared between the groups.Associa-tion with clinicopathological characteristics of gastric cancer patients were analyzed.The predictive values of each marker for gastric cancer occurrence and prognosis were evaluated using the area under the receiver operating characteristic curve(AUC).Three-year overall survival(OS)rates of gastric cancer patients were compared between different expression level groups using Kaplan-Meier survival curves.Results Serum levels of miR-518a-3p(1.98±0.45)and miR-376c-3p(0.99±0.34)in the case group were significantly lower than those in the control group(4.12±1.23,3.67±1.23,respectively),while serum sPD-L1(4.67±1.77)and sCTLA-4(10.21±2.34)levels were significantly higher than those in the control group(1.51±0.45,4.79±1.55,respectively)(t=21.694~27.971,all P<0.05).Deseased patients had significantly higher serum sPD-L1(6.02±1.47)and sCTLA-4(11.67±2.89)levels and significantly lower miR-518a-3p(1.89±0.56)and miR-376c-3p(1.07±0.31)levels compared with surviving group(3.78±1.64,6.56±1.59,3.68±1.29,and 3.45±1.23,respectively)(t=9.571~17.251,all P<0.05).ROC analysis indicated that the combined use of the four markers for diagnosing gastric cancer yielded an AUC of 0.992,significantly higher than that of each marker alone(Z=3.759~6.103,all P<0.001).The combined pre-dictive AUC for prognosis was 0.997,also significantly higher than individual markers(Z=2.176~5.534,all P<0.05).All four markers were significantly associated with TNM stage,tumor diameter,lymph node metastasis,tumor differentiation grade,and distant metastasis(miR-514b-3p:t=10.490~14.274;miR-376c-3p:t=13.021~16.528;sPD-L1:t=6.143~8.204;sCTLA-4:t=8.626~13.183,all P<0.05).Kaplan-Meier survival curves revealed significantly lower OS in patients with low miR-518a-3p and miR-376c-3p expression compared to high expression groups(Log-rank χ2=82.138,158.448,both P<0.05),while patients with high expression of sPD-L1 or sCTLA-4 had significantly poorer OS than those with low expression(Log-rank χ2=42.328,139.243,both P<0.05).Conclusions Low serum expression of miR-518a-3p and miR-376c-3p,along with high expression of sPD-L1 and sCTLA-4,are significantly associated with clinicopathological characteristics and poor prognosis in gastric cancer patients.Combined assessment of these four markers holds significant clinical value for prognostic evaluation of gastric cancer.
颜红莲;陈欣
滁州市第一人民医院肿瘤内科,安徽 滁州 239000滁州市第一人民医院肿瘤内科,安徽 滁州 239000
医药卫生
胃癌miR-518a-3pmiR-376c-3p可溶性程序性死亡-配体1可溶性细胞毒性T淋巴细胞相关抗原4
gastric cancermiR-518a-3pmiR-376c-3psoluble programmed death-ligand 1soluble cytotoxic T-lymphocyte-associated antigen 4
《现代检验医学杂志》 2026 (5)
58-63,6
2022年度安徽省卫生健康委科研项目(AHWJ2022c061).
评论